Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Genetic Markers of Knee Osteoarthritis in Women from Russia. | Biomedicines | 2024 | 38672138 | PubTator, text mining | PubMed |
| Illuminating ligand-induced dynamics in nuclear receptors through MD simulations. | Biochim Biophys Acta Gene Regul Mech | 2024 | 38614450 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes overexpressing SRC-3 protect mice from cerebral ischemia by inhibiting ferroptosis. | Brain Res Bull | 2024 | 38614406 | PubTator, text mining | PubMed |
| The Molecular Evolution of Melanoma Distant Metastases. | J Invest Dermatol | 2024 | 38582370 | PubTator, text mining | PubMed |
| GWAS-Informed data integration and non-coding CRISPRi screen illuminate genetic etiology of bone mineral density. | bioRxiv | 2024 | 38562830 | PubTator, text mining | PubMed |
| Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. | J Med Chem | 2024 | 38551814 | PubTator, text mining | PubMed |
| Androgen receptor cofactors: A potential role in understanding prostate cancer. | Biomed Pharmacother | 2024 | 38417290 | PubTator, text mining | PubMed |
| Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells. | Apoptosis | 2024 | 38393643 | PubTator, text mining | PubMed |
| GTF2H4 regulates partial EndMT via NF-κB activation through NCOA3 phosphorylation in ischemic diseases. | Innovation (Camb) | 2024 | 38379791 | PubTator, text mining | PubMed |
| Pediatric NCOA3-rearranged low-grade fibroblastic tumor with nuclear beta-catenin immunoreactivity. | Genes Chromosomes Cancer | 2024 | 38340030 | PubTator, text mining | PubMed |
| Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. | J Cancer Res Clin Oncol | 2024 | 38305916 | PubTator, text mining | PubMed |
| Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells. | Heliyon | 2024 | 38304813 | PubTator, text mining | PubMed |
| MIWE: detecting the critical states of complex biological systems by the mutual information weighted entropy. | BMC Bioinformatics | 2024 | 38280998 | PubTator, text mining | PubMed |
| Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases. | Medicina (Kaunas) | 2024 | 38276058 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis. | Heliyon | 2024 | 38268819 | PubTator, text mining | PubMed |
| ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. | Cancer Cell Int | 2024 | 38178183 | PubTator, text mining | PubMed |
| Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling. | Mol Cell Proteomics | 2024 | 38122900 | PubTator, text mining | PubMed |
| Androgen Receptor-Interacting Proteins in Prostate Cancer Development and Therapy Resistance. | Am J Pathol | 2024 | 38104650 | PubTator, text mining | PubMed |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. | J Mol Med (Berl) | 2024 | 37978056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=7